MP35-14 A 17-GENE ASSAY DRIVES HIGH ACTIVE SURVEILLANCE PERSISTENCE IN CLINICALLY LOW-RISK PROSTATE CANCER: 1 YEAR RESULTS FROM A 1,200 PATIENT PROSPECTIVE OBSERVATIONAL TRIAL
Author(s) -
Neal D. Shore,
Gregg Eure,
Daniel R. Saltzstein,
John P. Bennett,
Ruixiao Lu,
Phillip G. Febbo,
Béla Dénes
Publication year - 2018
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2018.02.1127
Subject(s) - medicine , prostate cancer , overdiagnosis , observational study , clinical endpoint , cancer , gynecology , oncology , clinical trial
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom